EA
CDMO

Emerald Acquisition’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Emerald Acquisition’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$32K Hold
10,914
– – ﹤0.01% 2918
2016
Q2 		$28K Buy
+10,914
New +$30.4K ﹤0.01% 2949

Other funds holding CDMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Emerald Acquisition's CDMO Position: Q3 2016 in Review

Emerald Acquisition held its Avid Bioservices, Inc. Common Stock (CDMO) position steady in Q3 2016 at 10,914 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #2918.

Emerald Acquisition first reported a position in CDMO in Q2 2016 and has held it in 2 quarters since. 66 funds tracked by Wall St. Rank hold CDMO as of Q3 2016.

  • Emerald Acquisition held 10,914 shares of Avid Bioservices, Inc. Common Stock worth $32K as of Q3 2016.
  • Emerald Acquisition left its Avid Bioservices, Inc. Common Stock share count unchanged in Q3 2016.
  • Avid Bioservices, Inc. Common Stock made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2918 holding.
  • Emerald Acquisition first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2016 and has held it in 2 quarters since.
  • 66 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.